![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Author: Zhang Y. Cao E.-H. Liang X.-Q. Qin J.-F.
Publisher: Elsevier
ISSN: 0014-2999
Source: European Journal of Pharmacology, Vol.474, Iss.2, 2003-08, pp. : 141-147
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Arsenic trioxide in the treatment of haematological malignancies
Expert Opinion on Drug Safety, Vol. 3, Iss. 6, 2004-11 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Arsenic trioxide for the treatment of myelodysplastic syndromes
By Vey Norbert
Expert Opinion on Pharmacotherapy, Vol. 5, Iss. 3, 2004-03 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Arsenic trioxide: Pleural and pericardial effusions: case report
Reactions Weekly, Vol. 1, Iss. 1294, 2010-01 ,pp. :